Project 170627

Role of microRNA in Major Depression and Suicide

170627

Role of microRNA in Major Depression and Suicide

$767,298
Project Information
Study Type: Other Biomarker_Study
Therapeutic Area: Mental_Health
Research Theme: Biomedical
Disease Area: major depression, suicide
Data Type: Canadian
Institution & Funding
Principal Investigator(s): Turecki, Gustavo X
Co-Investigator(s): Gratton, Alain; Labbe, Aurelie; Mechawar, Naguib; Pavlidis, Paul
Institution: CIUSSS de l'Ouest-de-l'Ile-de-Montréal-Douglas Hospital
CIHR Institute: Neurosciences, Mental Health and Addiction
Program: Operating Grant
Peer Review Committee: Behavioural Sciences - B: Clinical Behavioural Sciences
Competition Year: 2008
Term: 5 yrs 0 mth
Abstract Summary

The major objective of this proposal is to identify microRNA differences in prefrontal cortex and hippocampus of depressed suicides compared to controls. MicroRNA are small, noncoding RNA molecules that regulate RNA expression.

Research Characteristics

This project includes the following research characteristics:

Novel Biostatistics
Comorbidity Focus
Biobank Use
Knowledge Translation Focus
Biomarker Endpoints
Vulnerable Populations
Study Justification

"identify microRNA differences in prefrontal cortex and hippocampus of depressed suicides compared to controls"

Novelty Statement

"investigating the role of microRNA, small noncoding RNA molecules that regulate RNA expression, in major depression and suicide"

Methodology Innovation

investigating microRNA expression differences in brain regions of suicide cases

Keywords
Major Depression Microrna Neurobiology Suicide Vulnerability